Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Teva
Queensland Health
McKesson
Dow
McKinsey
Express Scripts
QuintilesIMS
US Department of Justice
Covington

Generated: August 17, 2017

DrugPatentWatch Database Preview

MESNA Drug Profile

« Back to Dashboard

What is the patent landscape for Mesna, and when can generic versions of Mesna launch?

Mesna is a drug marketed by Fresenius Kabi Usa, Sagent Pharms, West-ward Pharms Int, Mylan Labs Ltd, Teva Pharms Usa, and Mylan Institutional. and is included in six NDAs.

The generic ingredient in MESNA is mesna. There are ten drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the mesna profile page.

Summary for Tradename: MESNA

Patents:0
Applicants:6
NDAs:6
Suppliers / Packagers: see list5
Bulk Api Vendors: see list72
Clinical Trials: see list128
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MESNA at DailyMed

Pharmacology for Tradename: MESNA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
MESNA
mesna
INJECTABLE;INTRAVENOUS075811-001Apr 26, 2001APRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
MESNA
mesna
INJECTABLE;INTRAVENOUS203364-001Jul 18, 2014APRXNoNo► Subscribe► Subscribe► Subscribe
Sagent Pharms
MESNA
mesna
INJECTABLE;INTRAVENOUS090913-001Apr 13, 2010APRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
MESNA
mesna
INJECTABLE;INTRAVENOUS075739-001Jan 9, 2004APRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Institutional
MESNA
mesna
INJECTABLE;INTRAVENOUS076488-001Mar 8, 2012APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Teva
AstraZeneca
Baxter
Dow
Julphar
Colorcon
Merck
Cipla
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot